Mercado de oxigenadores cardiopulmonares: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00029843
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 236
Buy Now

[Informe de investigación]Se espera que el mercado mundial de oxigenadores cardiopulmonares crezca de 716,21 millones de dólares en 2022 a 904,15 millones de dólares en 2028; se prevé que registre una tasa compuesta anual del 4,0 % entre 2022 y 2028.

En 2022, América del Norte tuvo la mayor cuota de mercado, siendo Estados Unidos el mayor contribuyente al mercado en esta región. El crecimiento del mercado se atribuye a la creciente prevalencia de trastornos cardiovasculares y respiratorios, lo que ha aumentado la incidencia de trastornos cardiopulmonares como la EPOC, la bronquitis crónica y la insuficiencia cardíaca congestiva. Por ejemplo, según la Asociación Estadounidense del Pulmón, ~12,5 millones de personas fueron diagnosticadas con EPOC, bronquitis crónica y enfisema en los EE. UU. en 2020. Además, la creciente prevalencia e incidencia de dichos trastornos ha aumentado el número de procedimientos quirúrgicos entre un gran número de pacientes. población, lo que ha impulsado el crecimiento del mercado de oxigenadores cardiopulmonares. Por ejemplo, según un estudio publicado por Lifespan Health System, cada año se realizan alrededor de 500.000 cirugías a corazón abierto en los EE. UU. Además, se espera que un aumento en la prevalencia de insuficiencia respiratoria y enfermedades infecciosas genere la demanda de oxigenadores cardiopulmonares en los próximos años.

Además, la creciente prevalencia de trastornos cardiovasculares es la principal causa de muerte a nivel mundial, y los oxigenadores pueden ser de gran ayuda en casos de emergencia que salvan vidas. Según la Organización Mundial de la Salud, aproximadamente 17,9 millones de vidas se pierden anualmente debido a enfermedades cardiovasculares. Además, también se espera que las políticas de reembolso favorables creen amplias oportunidades para el crecimiento del mercado de oxigenadores cardiopulmonares en los próximos años. Por lo tanto, se espera que la creciente prevalencia e incidencia de trastornos cardiopulmonares impulsen el crecimiento del mercado de oxigenadores cardiopulmonares durante el período de pronóstico.

Mercado de oxigenadores cardiopulmonares:

Cardiopulmonary Oxygenator Market: Strategic Insights

Cardiopulmonary Oxygenator Market

  • CAGR (2022 - 2028)
    4.0%
  • Market Size 2022
    US$ 716.21 Million
  • Market Size 2028
    US$ 904.15 Million

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Eurosets SRL
  • Nipro Medical Corp
  • Fresenius Medical Care AG & Co. KGaA
  • MicroPort Scientific Corp
  • Braile Biomédica Industry, Commerce and Representations Ltd

Regional Overview

  • América del Norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Market Segmentation

Producto
  • oxigenador de burbujas y oxigenador de membrana
Aplicación
  • cardíaca y respiratoria
Tipo
  • oxigenador cardiopulmonar desechable y oxigenador cardiopulmonar reutilizable
Grupo de edad
  • adultos
  • pediátricos y recién nacidos

Uso de dispositivo ECMO portátil Acelera el crecimiento del mercado de oxigenación cardiopulmonar.

La primera tecnología ECMO se introdujo en más de 60 años. El primer modelo comercializado era enorme en tamaño y forma. Con la introducción de una versión portátil del sistema ECMO, los médicos ahora se sienten cómodos mientras tratan a pacientes que padecen EPOC crónica o insuficiencia cardíaca. La nueva tecnología portátil es revolucionaria por su tamaño compacto; También es una opción ideal en terapia con dispositivo de asistencia ventricular izquierda (DAVI) o trasplante de pulmón. La máquina portátil le da al médico tiempo suficiente para acceder a la situación de los órganos del paciente. Las pequeñas máquinas portátiles son beneficiosas para los pacientes que se someten a más de un trasplante de órganos. Así, las máquinas ECMO portátiles se perfilan como una tendencia futurista en el mercado de los oxigenadores cardiopulmonares. Algunos sistemas ECMO están destinados al transporte intrahospitalario, mientras que otros están destinados al transporte interhospitalario de pacientes. El nuevo oxigenador Capiox NX19 ayuda a minimizar el impacto del bypass cardiopulmonar al reducir la hemodilución, minimizar la respuesta inflamatoria y ayudar a la eliminación altamente eficiente de microémbolos gaseosos (GME).

regiones lucrativas para el mercado de oxigenadores cardiopulmonares

Perspectivas del mercado: Mercado de oxigenadores cardiopulmonares

Según la región, el mercado de oxigenadores cardiopulmonares está segmentado en América del Norte, Europa, Asia Pacífico, América del Sur y Oriente Medio y Oriente Medio. África. América del Norte dominó la cuota de mercado de oxigenadores cardiopulmonares en 2022. El mercado de esta región está aún más segmentado en EE. UU., Canadá y México. El crecimiento del mercado de oxigenadores cardiopulmonares de América del Norte se atribuye a la creciente prevalencia de trastornos cardiovasculares y respiratorios en la región. Esto ha aumentado la incidencia de trastornos cardiopulmonares como la EPOC, la bronquitis crónica y la insuficiencia cardíaca congestiva. Por ejemplo, según la Asociación Estadounidense del Pulmón, ~12,5 millones de personas fueron diagnosticadas con EPOC, bronquitis crónica y enfisema en los EE. UU. en 2020. Por lo tanto, se espera que la creciente prevalencia e incidencia de trastornos cardiopulmonares impulsen el crecimiento del mercado de oxigenadores cardiopulmonares durante el pronóstico. período.

Información basada en el producto

Según el producto, el mercado de oxigenadores cardiopulmonares se divide en oxigenador de membrana y oxigenador de burbuja. El segmento de oxigenadores de membrana tuvo una mayor participación de mercado en 2022 y se prevé que registre una CAGR más alta durante el período de pronóstico (2022-2028). Se espera que los oxigenadores de membrana de tecnología avanzada impulsen el crecimiento del mercado de oxigenadores cardiopulmonares durante el período de pronóstico.

Mercado de oxigenadores cardiopulmonares, por producto: 2022 y 2028

El mercado de oxigenadores cardiopulmonares está segmentado según el producto, la aplicación, el tipo, el grupo de edad y el uso final. Según el producto, el mercado de oxigenadores cardiopulmonares se divide en oxigenadores de burbujas y oxigenadores de membrana. En términos de aplicación, el mercado de oxigenadores cardiopulmonares se divide en cardíaco y respiratorio. Según el tipo, el mercado se divide en oxigenador cardiopulmonar desechable y oxigenador cardiopulmonar reutilizable. Según el grupo de edad, el mercado de oxigenadores cardiopulmonares se segmenta en adultos, pediátricos y recién nacidos. Según el uso final, el mercado de oxigenadores cardiopulmonares se segmenta en hospitales y clínicas, centros quirúrgicos ambulatorios y otros. Según la geografía, el mercado de oxigenadores cardiopulmonares está segmentado principalmente en América del Norte, Europa, Asia Pacífico (APAC), Medio Oriente y Asia. África (MEA) y América del Sur (SAM).

Los principales actores del mercado que operan en el mercado de oxigenadores cardiopulmonares son Getinge AB, LivaNova Plc, Medtronic Plc, Terumo Corp, Eurosets SRL, Nipro Medical Corp, Fresenius Medical Care AG & Co. KGaA, MicroPort Scientific Corp, Braile Biomédica Industry, Commerce and Representations Ltd y Chalice Medical Ltd.

Los actores del mercado de oxigenadores cardiopulmonares se centran principalmente en la aprobación de productos y la expansión de la empresa para crear valor para el cliente.< /p>

  • En noviembre de 2022, LivaNova PLC anunció que recibió la autorización 510(k) para oxigenación por membrana extracorpórea (ECMO) de la Administración de Alimentos y Medicamentos de EE. UU. (FDA) para LifeSPARC, la próxima generación de la compañía. Sistema de control y bomba de soporte circulatorio avanzado (ACS).
  • En febrero de 2022, Fresenius Medical Care anunció que la Administración de Alimentos y Medicamentos de EE. UU. (FDA) había autorizado Novalung, un sistema de soporte cardíaco y pulmonar para el tratamiento de insuficiencia respiratoria o cardiopulmonar aguda. Novalung es el primer sistema de oxigenación por membrana extracorpórea (ECMO) autorizado para más de seis horas de uso como soporte vital extracorpóreo.
  • En diciembre de 2020, Nipro Medical Corp anunció que Nipro Australia PTY LTD, su filial consolidada , había establecido una oficina de ventas en Melbourne, Victoria, Australia.

Cardiopulmonary Oxygenator Market Report Scope

Report Attribute Details
Market size in US$ 716.21 Million
Market Size by US$ 904.15 Million
Global CAGR
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Producto
  • oxigenador de burbujas y oxigenador de membrana
By Aplicación
  • cardíaca y respiratoria
By Tipo
  • oxigenador cardiopulmonar desechable y oxigenador cardiopulmonar reutilizable
By Grupo de edad
  • adultos
  • pediátricos y recién nacidos
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • resto de Europa
Asia-Pacífico
  • China
  • India
  • Japón
  • Australia
  • resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Market leaders and key company profiles
  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Eurosets SRL
  • Nipro Medical Corp
  • Fresenius Medical Care AG & Co. KGaA
  • MicroPort Scientific Corp
  • Braile Biomédica Industry, Commerce and Representations Ltd
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    Who are the key players in the cardiopulmonary oxygenator market?

    Companies operating in the market are Getinge AB, LivaNova Plc, Medtronic Plc, Terumo Corp, Eurosets SRL, Nipro Medical Corp, Fresenius Medical Care AG & Co. KGaA, MicroPort Scientific Corp, Braile Biomédica Industry, Commerce and Representations Ltd, and Chalice Medical Ltd.

    What is the regional market scenario of the cardiopulmonary oxygenator market?

    Global home infusion therapy market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the home infusion therapy market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

    Which application segment held the largest revenue (US$ Mn) in the cardiopulmonary oxygenator market?

    The cardiopulmonary oxygenators market, by application, is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2021 and is anticipated to register a higher CAGR during the forecast period (2022–2028).

    What are the driving factors for the cardiopulmonary oxygenator market across the globe?

    Key factors driving the market growth are rising incidences of cardiopulmonary diseases and increasing surgical procedures with surging in aging population.

    Which product segment led cardiopulmonary oxygenator market?

    The cardiopulmonary oxygenators market, by product, is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2021 and is anticipated to register a higher CAGR during the forecast period (2022–2028).

    What is meant by the cardiopulmonary oxygenator market?

    The oxygenator removes carbon dioxide and adds oxygen to the blood that is pumped into the arterial system. The blood pumped back into the patient’s arteries is sufficient to maintain life at even the most distant parts of the body as well as in the organs. Cardiopulmonary bypass (CPB) procedures require a blood-gas exchanger (oxygenator) to replace the respiratory function of the lungs temporarily. In the past the majority of CPB procedures have been carried out with bubble oxygenators which effect gas exchange by dispersion of bubbles into the blood. Membrane oxygenators, on the other hand, utilize a hydrophobic gas permeable membrane between the blood and gas phases. Bubble oxygenators are being superseded by membrane types for CPB due to improvements in membrane technology and mass transfer efficiency.

    The List of Companies - Cardiopulmonary Oxygenator Market

    1. Getinge AB
    2. LivaNova Plc
    3. Medtronic Plc
    4. Terumo Corp
    5. Eurosets SRL
    6. Nipro Medical Corp
    7. Fresenius Medical Care AG & Co. KGaA
    8. MicroPort Scientific Corp
    9. Braile Biomédica Industry, Commerce and Representations Ltd
    10. Chalice Medical Ltd.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports